rs199800166
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2
The NM_013275.6(ANKRD11):c.2684G>A(p.Arg895Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000204 in 1,614,116 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_013275.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANKRD11 | NM_013275.6 | c.2684G>A | p.Arg895Gln | missense_variant | Exon 9 of 13 | ENST00000301030.10 | NP_037407.4 | |
ANKRD11 | NM_001256182.2 | c.2684G>A | p.Arg895Gln | missense_variant | Exon 10 of 14 | NP_001243111.1 | ||
ANKRD11 | NM_001256183.2 | c.2684G>A | p.Arg895Gln | missense_variant | Exon 9 of 13 | NP_001243112.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152160Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 250974Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135702
GnomAD4 exome AF: 0.00000684 AC: 10AN: 1461838Hom.: 0 Cov.: 38 AF XY: 0.00 AC XY: 0AN XY: 727214
GnomAD4 genome AF: 0.000151 AC: 23AN: 152278Hom.: 0 Cov.: 32 AF XY: 0.000134 AC XY: 10AN XY: 74474
ClinVar
Submissions by phenotype
KBG syndrome Uncertain:1
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 895 of the ANKRD11 protein (p.Arg895Gln). This variant is present in population databases (rs199800166, gnomAD 0.003%). This missense change has been observed in individual(s) with intellectual disability, ataxia and dismorphic facial features (PMID: 30919572). ClinVar contains an entry for this variant (Variation ID: 430379). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt ANKRD11 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not provided Uncertain:1
Missense variant in a gene in which most reported pathogenic variants are truncating/loss-of-function; In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 30919572, 27535533) -
ANKRD11-related disorder Uncertain:1
The ANKRD11 c.2684G>A variant is predicted to result in the amino acid substitution p.Arg895Gln. This variant was reported as likely pathogenic in a male patient with intellectual disability, speech delay, ataxia, and dysmorphic facial features including high nasal bridge and prominent chin (Table S1 & S3, Al-Dewik et al 2019. PubMed ID: 30919572). However, conclusive evidence of pathogenicity was not presented. This variant is reported in 0.0029% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/16-89350266-C-T). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at